Novotech Releases Comprehensive Report on Oncolytic Virus Therapy
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122884484/en/
Oncolytic virus therapies utilize genetically modified or naturally occurring viruses to selectively target tumor cells and stimulate immune responses. This dual mechanism is creating new possibilities in oncology and other therapeutic areas.
Key Highlights:
- Global Trial Landscape: Asia-Pacific leads with 40% of OVT clinical trials, followed closely by North America and Europe, reflecting a global focus on advancing these therapies.
- Pipeline Insights: Solid tumors dominate OVT research, with trials targeting cancers such as melanoma, glioblastoma, and pancreatic cancer.
- Innovative Delivery Systems: Advances like nanoparticle systems and cell-based carriers address key challenges in targeting and delivery.
- Combination Therapies: Integration with immune checkpoint inhibitors, CAR-T therapies, and chemotherapy is enhancing the efficacy and scope of OVT.
- Regulatory Overview: Provides guidance on navigating complex global regulatory pathways, including insights into fast-tracking approvals.
This complimentary report offers biotech and pharmaceutical companies, data-driven analysis to navigate the complexities of clinical trials and regulatory frameworks in oncolytic virus therapy.
About NovotechNovotech-CRO.com
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech and small to mid-size companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Fierce CRO 2024 Excellence Award in Clinical Trial Management and Global Operations, Frost & Sullivan 2024 Global Biotech CRO of the year award, Clinical Trials Arena 2024 Excellence Awards in Business Expansion, Innovation and Marketing, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
For more information or to speak to an expert team member visit www.Novotech-CRO.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122884484/en/
Contacts
Media
Toyna Chin
mediacontact@novotech-cro.com
USA: +1 415 364 8135
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoStar Group Partnership to Enhance Market Insights and Drive Growth for New Client Bray Fox Smith22.1.2025 18:32:00 EET | Press release
CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group,” “we” or “our”), a leading provider of online real estate marketplaces, information, and analytics in the property markets, has announced a new client partnership with Bray Fox Smith, a London-based commercial property consultancy focusing on Office Agency and Multi-Sector Investment and Development. This partnership will allow Bray Fox Smith to leverage CoStar’s unrivalled commercial real estate data and analytics platform to drive business growth and deliver enhanced advisory services. With access to CoStar’s extensive insights on property values, market conditions, occupancy levels, and availability, Bray Fox Smith’s team will be well-equipped to uncover a greater number of new opportunities and better understand value in the market. “At CoStar Group, we are dedicated to providing our forward-looking clients with industry-leading insights and tools they need to excel in the commercial real estate market,” said Andy Florance, Founder
Sia Unveils New Name and Refreshed Branding22.1.2025 18:17:00 EET | Press release
This evolution reflects the firm’s commitment to optimism and unwavering focus on helping clients achieve the best possible outcomes in their transformation journeys. The refreshed brand is more than just a new look—it’s a renewed purpose. The move is designed to inspire fresh perspectives, grounded in the belief that what you can get out of change depends on how you approach it. Sia is presenting its consultants as ‘Optimists for change’, emphasizing its core business of helping clients to profit from opportunity and to overcome challenges. CEO, Matthieu Courtecuisse, shares: “As AI, climate change and cyber threats bring new challenges and opportunities, Sia is well positioned to help our clients respond. We are a next generation consultancy, born digital, augmented by data science, enhanced by creativity and driven by responsibility". “Our revised name is simpler and more memorable for us and for our clients. Our positioning of ‘Optimists for change’ reflects our ‘Can do’ attitude.
Rimini Street Announces Rimini Protect ™ Advanced Hypervisor Security for VMware, Nutanix and All Other Linux-Based Hypervisors, Powered by Vali Cyber ® , to Safeguard Against Ransomware and Other Vulnerabilities22.1.2025 16:00:00 EET | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, the leading third-party support provider for Oracle, SAP and VMware software, today announced the general availability of Rimini Protect™ Advanced Hypervisor Security (AHS), an exclusive solution powered by proven Vali Cyber® AI/ML security technology. The Rimini Protect AHS solution leverages these innovative capabilities that are already protecting mission-critical hypervisor infrastructure, including US military VMware deployments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122401764/en/ Rimini Street Announces Rimini Protect™ Advanced Hypervisor Security for VMware, Nutanix and All Other Linux-Based Hypervisors, Powered by Vali Cyber®, to Safeguard Against Ransomware and Other Vulnerabilities (Graphic: Business Wire) The Rimini Protect AHS solution combines Vali Cyber technology with Rimini Str
Qualcomm Schedules First Quarter Fiscal 2025 Earnings Release and Conference Call22.1.2025 16:00:00 EET | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company’s financial results for its first quarter fiscal 2025 on Wednesday, February 5, 2025, after the close of the market on the Company’s Investor Relations website, at https://investor.qualcomm.com/financial-information. The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov. Qualcomm will host a conference call to discuss its first quarter fiscal 2025 results which will be broadcast live on February 5, 2025, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/investor-events/default.aspx. An audio replay will be available at https://investor.qualcomm.com/news-events/investor-events/default.aspx and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international call
Improbable Leverages Improved Financial Profile to Drive Innovation in AI, the Metaverse, and Web3 Through Venture Building22.1.2025 15:00:00 EET | Press release
Improbable, a venture builder dedicated to growing businesses across AI, the metaverse, and Web3 ecosystems, has capped off a transformative 2024 with the announcement of the profitability threshold achieved in the previous financial year, a change in business model, and significant progress across interconnected ecosystems. Central to its success is the company’s venture-building model, which has proven instrumental in creating businesses and technologies that shape the future of virtual worlds and digital economies. Venture Building: Driving Innovation Across Ecosystems and Building the Open Metaverse Improbable’s venture-building strategy has been key to addressing challenges and unlocking opportunities across frontier ecosystems. In 2024, the company launched several new ventures, including: Kallikor, an AI-powered platform accelerating the adoption of robotics in supply chains. Jitter, transforming Twitch streams into interactive multiplayer games. Chamber, a next-gen platform ble
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom